Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
Status:
Completed
Trial end date:
2021-03-09
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies the effects of aspirin and zileuton on genes related
to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to
tobacco use and may be useful in preventing lung cancer in current smokers.